Andembry, which is administered subcutaneously using an auto-injector pen, provides less frequent dosing Takeda's big-selling kallikrein inhibitor Takhzyro (lanadelumab), which requires a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback